Not sure but seems like we're in the denial stage here. The excuses being aired are really reaching out there. Intellectual jealousy while valid would not get in the way of progress of a real breakthrough in cancer research which supposedly is being backed by 2 major firms. As far as the quarterly report for a company which has very little revenue and activity since the last quarterly report should not be a daunting task. The lack of communication with the shareholders for months has a lot to do with the poor performance of the security. A little straight talk seems to be lacking and is certainly not attracting new investors.